Short Interest in Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Drops By 11.1%

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOFGet Rating) was the recipient of a significant decrease in short interest in August. As of August 31st, there was short interest totalling 888,000 shares, a decrease of 11.1% from the August 15th total of 999,000 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 8,880.0 days.

Kyowa Kirin Stock Performance

Shares of KYKOF stock opened at $22.94 on Monday. The stock’s fifty day moving average is $22.98 and its 200-day moving average is $23.25. Kyowa Kirin has a 52 week low of $21.22 and a 52 week high of $23.85.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group upgraded Kyowa Kirin from a “neutral” rating to a “buy” rating in a research note on Tuesday, July 12th.

About Kyowa Kirin

(Get Rating)

Kyowa Kirin Co, Ltd. manufactures and markets pharmaceuticals that focuses on the therapeutic areas of oncology, nephrology, central nervous system, and immunology worldwide. Its products include ABSTRAL, a sublingual formulation of fentanyl used for the management of episodes of breakthrough pain experienced by cancer patients; ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.

See Also

Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.